Comorbidities and COPD severity in a clinic-based cohort - Archive ouverte HAL
Article Dans Une Revue BMC Pulmonary Medicine Année : 2018

Comorbidities and COPD severity in a clinic-based cohort

A. Bernady
  • Fonction : Auteur
J. Casteigt
  • Fonction : Auteur
C. Nocent-Eijnani
  • Fonction : Auteur
L. Falque
  • Fonction : Auteur
F. Le Guillou
  • Fonction : Auteur
L. Nguyen
  • Fonction : Auteur
A. Ozier
  • Fonction : Auteur
Mathieu Molimard

Résumé

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality around the world. The aim of our study was to determine the association between specific comorbidities and COPD severity. METHODS: Pulmonologists included patients with COPD using a web-site questionnaire. Diagnosis of COPD was made using spirometry post-bronchodilator FEV1/FVC < 70%. The questionnaire included the following domains: demographic criteria, clinical symptoms, functional tests, comorbidities and therapeutic management. COPD severity was classified according to GOLD 2011. First we performed a principal component analysis and a non-hierarchical cluster analysis to describe the cluster of comorbidities. RESULTS: One thousand, five hundred and eighty-four patients were included in the cohort during the first 2 years. The distribution of COPD severity was: 27.4% in group A, 24.7% in group B, 11.2% in group C, and 36.6% in group D. The mean age was 66.5 (sd: 11), with 35% of women. Management of COPD differed according to the comorbidities, with the same level of severity. Only 28.4% of patients had no comorbidities associated with COPD. The proportion of patients with two comorbidities was significantly higher (p < 0.001) in GOLD B (50.4%) and D patients (53.1%) than in GOLD A (35.4%) and GOLD C ones (34.3%). The cluster analysis showed five phenotypes of comorbidities: cluster 1 included cardiac profile; cluster 2 included less comorbidities; cluster 3 included metabolic syndrome, apnea and anxiety-depression; cluster 4 included denutrition and osteoporosis and cluster 5 included bronchiectasis. The clusters were mostly significantly associated with symptomatic patients i.e. GOLD B and GOLD D. CONCLUSIONS: This study in a large real-life cohort shows that multimorbidity is common in patients with COPD.
Fichier principal
Vignette du fichier
BPH_BMCPM_2018_Raherison.pdf (656.57 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03164958 , version 1 (10-03-2021)

Licence

Identifiants

Citer

Chantal Raherison, El Hassane Ouaalaya, A. Bernady, J. Casteigt, C. Nocent-Eijnani, et al.. Comorbidities and COPD severity in a clinic-based cohort. BMC Pulmonary Medicine, 2018, 18 (1), pp.117. ⟨10.1186/s12890-018-0684-7⟩. ⟨hal-03164958⟩

Collections

U1219
15 Consultations
18 Téléchargements

Altmetric

Partager

More